Article
Author(s):
New York - A single IV injection of anti-IL-12 antibody, even at low doses, resulted in significant improvement in PASI scores, according to results of a study presented at the recent International Psoriasis Symposium, held here.
Daily Derm Times: March 31, 2025
Derm Dispatch: A Comprehensive Guide to Managing Eczema with Integrative Medicine
Celebrating Women’s History Month 2025 with Dermatology Times
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Q1 Dermatology Drug & Device Report: FDA Approvals & Pipeline Updates
PASI and QoL: A New Approach to Treatment Goals